iBio Reports Q1 FY2027 Revenue of $1.1 Million and Net Loss of $7.6 Million

iBio reported first-quarter fiscal 2027 revenue of $1.075 million and a net loss of $7.551 million for the three months ended September 30, 2026. Operating loss was $8.338 million, compared with $5.951 million a year earlier. The company also provided updates on its IBIO-610 and IBIO-600 developmen…